Combination Targeted Radiotherapy in Neuroendocrine Tumors

计划入组 2 人 · 首次发布于 2010 年 4 月 6 日

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

计划入组 400 人 · 首次发布于 2014 年 10 月 21 日

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

首次发布于 2014 年 6 月 25 日

Lutetium Lu 177 dotatate(Lutathera)

C₆₅H₈₇LuN₁₄O₁₉S₂

Copper oxodotreotide Cu-64

C₆₅H₈₈CuN₁₄O₁₉S₂

Lanreotide(Somatuline)

C₅₄H₆₉N₁₁O₁₀S₂ · Rx

Crinetics

United States

BioLine Rx

Israel

Kura Oncology

United States

European Commission Approves Cabometyx for Advanced Pancreatic Neuroendocrine Tumors

Cabozantinib Significantly Improves Progression-Free Survival in Advanced Neuroendocrine Tumors

Lutetium Lu 177 Dotatate Shows Promise in Metastatic Bronchopulmonary Neuroendocrine Tumors